| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.5795 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.6461 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.6494 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.6841 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.6900 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7159 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7329 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7367 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7475 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7480 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7553 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7792 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7802 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7966 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8145 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8158 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8173 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8209 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8285 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8332 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8353 | Peak area | Normal |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8386 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8551 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8556 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8581 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8619 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8682 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8707 | Peak area | Normal |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8951 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8961 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9015 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9079 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9116 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9179 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9191 | Peak area | Normal |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9193 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9232 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9337 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9393 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9468 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9501 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9553 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9576 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9597 | Peak area | Normal |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9617 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9652 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9668 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9720 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9722 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9736 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9868 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9922 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9964 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0036 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0053 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0097 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0162 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0242 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0306 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0321 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0467 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0589 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0597 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0622 | Peak area | Normal |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0917 | Peak area | Normal |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1042 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1087 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1161 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1225 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1317 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1317 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1336 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1350 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1630 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1789 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1814 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1816 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1912 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2057 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2083 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2164 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2181 | Peak area | Normal |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2457 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2464 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2531 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2593 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2768 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2993 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.3133 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.3302 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.3452 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.3538 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.3555 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.3756 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.4083 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.4180 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.4631 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.4710 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.4930 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.4932 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.5860 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.5959 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.6028 | Peak area | Normal |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.6511 | Peak area | Diabetic non neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.6513 | Peak area | Diabetic Neuropathy |
| HILIC POSITIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.6674 | Peak area | Normal |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|